tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sandoz price target raised to CHF 63 from CHF 60 at Deutsche Bank
PremiumThe FlySandoz price target raised to CHF 63 from CHF 60 at Deutsche Bank
1M ago
Sandoz Wins EU Approval for Ondibta Biosimilar Insulin, Bolstering Diabetes Push
Premium
Company Announcements
Sandoz Wins EU Approval for Ondibta Biosimilar Insulin, Bolstering Diabetes Push
1M ago
Sandoz Targets ‘Golden Decade’ as Patent Cliff Opens USD 600 Billion Generics and Biosimilars Opportunity
Premium
Company Announcements
Sandoz Targets ‘Golden Decade’ as Patent Cliff Opens USD 600 Billion Generics and Biosimilars Opportunity
1M ago
Sandoz Launches Denosumab Biosimilars in Europe to Expand Affordable Treatment Options
PremiumCompany AnnouncementsSandoz Launches Denosumab Biosimilars in Europe to Expand Affordable Treatment Options
3M ago
Sandoz Expands European Market with Afqlir® Launch for Retinal Diseases
Premium
Company Announcements
Sandoz Expands European Market with Afqlir® Launch for Retinal Diseases
3M ago
Sandoz price target raised to CHF 60 from CHF 55 at Deutsche Bank
Premium
The Fly
Sandoz price target raised to CHF 60 from CHF 55 at Deutsche Bank
3M ago
Sandoz Expands Biosimilar Capabilities with Just-Evotec Acquisition
PremiumCompany AnnouncementsSandoz Expands Biosimilar Capabilities with Just-Evotec Acquisition
4M ago
Sandoz participates in a conference call with Jefferies
Premium
The Fly
Sandoz participates in a conference call with Jefferies
4M ago
Sandoz Reports Strong Sales Growth and Upgraded Margin Guidance for 2025
Premium
Company Announcements
Sandoz Reports Strong Sales Growth and Upgraded Margin Guidance for 2025
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100